{"disease":{"id":"ototoxic-hearing-loss","name":"ototoxic hearing loss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06885411","title":"Ototoxicity in Patients With MoM Hip Bearings","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Reinier Haga Orthopedisch Centrum","has_results":false},{"nct_id":"NCT04291209","title":"Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT02099786","title":"Randomized Trial Comparison of Ototoxicity Monitoring Programs","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT07364747","title":"Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT04226456","title":"Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"Centre Hospitalier Universitaire Saint Pierre","has_results":false},{"nct_id":"NCT04766853","title":"Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Seoul National University Hospital","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}